Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 04 - 28 entities : Abbvie inc. save search
AbbVie Unites with Plexium to Leverage Protein Degraders Against Neurological Diseases
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
neurological disease
AbbVie Unites with Plexium to Leverage Protein Degradation Against Neurological Diseases
Published: 2022-04-28 (Crawled : 21:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
neurological disease
Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
collaboration neurological therapy
USD 438.03 Mn growth expected in Krabbe Disease Treatment Market | North America to emerge as key market | Technavio
Published: 2022-04-28 (Crawled : 16:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -3.19%
H: 1.56%
C: 1.56%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
GSK | News | $41.165 1.42% 1.3M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
america treatment disease growth market
Off to Stratospheric 2022 Start, AbbVie Announces New Protein Degradation Partnership
Published: 2022-04-28 (Crawled : 15:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
partnership
Off to Stratospheric 2022 Start, AbbVie Announces New Protein Degradation Par...
Published: 2022-04-28 (Crawled : 15:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Published: 2022-04-28 (Crawled : 13:20) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
care research eye
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.21 41.67% 5.6M
|
Technology Services
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
PALI | $6.29 27.59% 22M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.